Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: A randomized clinical-trial

Journal of Allergy and Clinical Immunology

Volumn 107, Issue 3, 2001, Pages 461-468

  Busse, William ^a   Raphael, Gordon D ^a   Galant, Stanley ^a   Kalberg, Chris ^a   Goode Sellers, Stacey ^a   Srebro, Sharon ^a   Edwards, Lisa ^a   Rickard, Kathy ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Asthma; Fluticasone propionate; Inhaled corticosteroid; Leukotriene modifier; Montelukast

Indexed keywords

FLUTICASONE PROPIONATE; MONTELUKAST;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT SATISFACTION; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; VITAL CAPACITY;

EID: 0035090601     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2001.114657     Document Type: Article

References (38)

1. Efficacy and safety of inhaled corticosteroids
2. First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma
3. Low-dose inhaled corticosteroids and the prevention of death from asthma
4. Inhaled steroids and the risk of hospitalization for asthma
5. Bronchoconstrictor effects of leukotriene C in humans
6. Effects of leukotriene D on the airways in asthma
7. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: A multicenter, randomized double-blind trial
8. The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma
9. Zafirlukast for symptomatic mild-to-moderate asthma: A 13-week multicenter study
10. Low dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma
11. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma
12. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma
13. Reference spitometric values using techniques and equipment that meet ATS recommendations
14. Statistical aspects of the analysis of data from retrospective studies of disease
15. Determining a minimal important change in a disease-specific quality of life questionnaire
16. Fluticasone propionate aerosol - Efficacy in patients with mild to moderate asthma
17. Low-dose inhaled fluticasone propionate versus oral zafirlukast in asthma patients
18. The placebo effect in asthma drug therapy trials: A meta-analysis
19. Fluticasone propionate versus zafirlukast: Effect in patients previously receiving inhaled corticosteroid therapy
20. Montelukast added to inhaled beclomethasone in treatment of asthma
21. Asthma controller medications: What do patients want?
22. Airway mucosal inflammation even in patients with newly diagnosed asthma
23. Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids
24. 2 translocation and leukotriene C4 secretion by fluticasone propionate in exogenously activated human eosinophils
25. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodelling in mild asthma: A placebo-controlled study
26. Glucocorticoids inhibit eosinophil responses to granulocyte-macrophage colony stimulating factor
27. Glucocorticoids inhibit cytokine-mediated eosinophil survival
28. Cytokines as mediators of chronic asthma
29. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children
30. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma
31. Effect of early vs late intervention with inhaled corticosteroids in asthma
32. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study
33. Effect of an inhaled corticosteroid on airway inflammation and symptoms of asthma
34. Effect of inhaled beclomethasone dipropionate on expression of proinflammatory cytokines and activated eosinophils in the bronchial epithelium of patients with mild asthma